XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)

NCT01120379 · clinicaltrials.gov ↗

COMPLETED

Status

5034

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Coronary Occlusion
Vascular Disease
Myocardial Ischemia
Coronary Artery Stenosis
Coronary Disease
Coronary Artery Disease
Coronary Restenosis

Interventions

DEVICE: XIENCE V® EECSS

Sponsor

Abbott Medical Devices